{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:10Z","timestamp":1793325670192,"version":"4.5.0"},"reference-count":203,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Serum amyloid A (SAA) is an acute phase protein with a significant importance for patients with inflammatory rheumatic diseases (IRD). The central role of SAA in pathogenesis of IRD has been confirmed by recent discoveries, including its involvement in the activation of the inflammasome cascade and recruitment of interleukin 17 producing T helper cells. Clinical utility of SAA in IRD was originally evaluated nearly half a century ago. From the first findings, it was clear that SAA could be used for evaluating disease severity and monitoring disease activity in patients with rheumatoid arthritis and secondary amyloidosis. However, cost-effective and more easily applicable markers, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), overwhelmed its use in clinical practice. In the light of emerging evidences, SAA has been discerned as a more sensitive biomarker in a wide spectrum of IRD, especially in case of subclinical inflammation. Furthermore, a growing number of studies are confirming the advantages of SAA over many other biomarkers in predicting and monitoring response to biological immunotherapy in IRD patients. Arising scientific discoveries regarding the role of SAA, as well as delineating SAA and its isoforms as the most sensitive biomarkers in various IRD by recently developing proteomic techniques are encouraging the revival of its clinical use. Finally, the most recent findings have shown that SAA is a biomarker of severe Coronavirus disease 2019 (COVID-19). The aim of this review is to discuss the SAA-involving immune system network with emphasis on mechanisms relevant for IRD, as well as usefulness of SAA as a biomarker in various IRD. Therefore, over a hundred original papers were collected through an extensive PubMed and Scopus databases search. These recently arising insights will hopefully lead to a better management of IRD patients and might even inspire the development of new therapeutic strategies with SAA as a target.<\/jats:p>","DOI":"10.3389\/fimmu.2020.631299","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T20:14:34Z","timestamp":1613852074000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":103,"title":["Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker"],"prefix":"10.3389","volume":"11","author":[{"given":"Iva","family":"Sori\u0107 Hosman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanka","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovro","family":"Lamot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0680233","article-title":"Comparative-study of serum amyloid-A protein and C-reactive protein in disease","volume":"68","author":"Maury","year":"1985","journal-title":"Clin Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.10.677","article-title":"Comparative-study of C-reactive protein and serum amyloid-A protein in experimental inflammation","volume":"50","author":"Chambers","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.138.11.3967","article-title":"Transcriptional regulation of genes encoding the acute-phase proteins CRP, SAA, and C3","volume":"138","author":"Goldberger","year":"1987","journal-title":"J Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2011.607189","article-title":"Kinetics of C-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times","volume":"16","author":"Takata","year":"2011","journal-title":"Biomarkers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.1780220106","article-title":"Serum amyloid A protein in amyloidosis, rheumatic, and neoplastic diseases","volume":"22","author":"Benson","year":"1979","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6375.1391","article-title":"Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis","volume":"286","author":"Falck","year":"1983","journal-title":"Br Med J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"Br Med J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(82)90321-x","article-title":"Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis","volume":"2","author":"De Beer","year":"1982","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.41.3.268","article-title":"Relationship between urinary sialylated saccharides, serum amyloid A protein and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus","volume":"41","author":"Maury","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2804","article-title":"Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis","volume":"11","author":"Shen","year":"2014","journal-title":"Mol Med Rep"},{"key":"B12","article-title":"Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells","volume":"26","author":"Kumon","year":"1999","journal-title":"J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"793628","DOI":"10.1155\/2014\/793628","article-title":"Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis","volume":"2014","author":"Targonska-Stepniak","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.42.6.665","article-title":"Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity","volume":"42","author":"Chambers","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"B15","first-page":"58","article-title":"Serum amyloid A in the assessment of early inflammatory arthritis","volume":"27","author":"Cunnane","year":"2000","journal-title":"J Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13075-017-1334-9","article-title":"Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis","volume":"19","author":"Yoo","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1699-0463.1985.tb02913.x","article-title":"Amyloid-related serum protein (SAA) during and after pregnancy in healthy women and women with rheumatic disease","volume":"93","author":"Ostensen","year":"1985","journal-title":"APMIS Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-016-1009-y","article-title":"Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker","volume":"18","author":"Hwang","year":"2016","journal-title":"Arthritis Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/13547500701669410","article-title":"Diagnosis of rheumatoid arthritis: multivariate analysis of biomarkers","volume":"13","author":"Wild","year":"2008","journal-title":"Biomarkers"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e66769","DOI":"10.1371\/journal.pone.0066769","article-title":"Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties","volume":"8","author":"De Seny","year":"2013","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"183653","DOI":"10.1155\/2013\/183653","article-title":"Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis","volume":"2013","author":"Ally","year":"2013","journal-title":"Mediators Inflamm"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s1734-1140(10)70329-7","article-title":"Influence of long-term leflunomide treatment on serum amyloid concentration in rheumatoid arthritis patients","volume":"62","author":"Targo\u0144ska-St\u0119pniak","year":"2010","journal-title":"Pharmacol Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.33455","article-title":"Acute-phase serum amyloid A regulates tumor necrosis factor alpha and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy","volume":"64","author":"Connolly","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e60635","DOI":"10.1371\/journal.pone.0060635","article-title":"Development of a multi-biomarker disease activity test for rheumatoid arthritis","volume":"8","author":"Centola","year":"2013","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13075-020-02240-w","article-title":"A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis","volume":"22","author":"Ma","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/art.10748","article-title":"Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation","volume":"48","author":"Wong","year":"2003","journal-title":"Arthritis Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.25009","article-title":"Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis","volume":"61","author":"Rho","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"B28","article-title":"Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis","volume":"24","author":"Kullich","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.07.034","article-title":"Chondrocyte of rheumatoid arthritis serve as a source of intra-articular acute-phase serum amyloid A protein","volume":"398","author":"Momohara","year":"2008","journal-title":"Clin Chim Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13075-019-1902-2","article-title":"ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation","volume":"21","author":"Boeters","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12234","article-title":"Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis","volume":"175","author":"Migita","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080755","article-title":"E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy","volume":"36","author":"Visvanathan","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes381","article-title":"Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial","volume":"52","author":"Doyle","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2014.140194","article-title":"Periodontal and serum protein profiles in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitor adalimumab","volume":"85","author":"Kobayashi","year":"2014","journal-title":"J Periodontol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"R178","DOI":"10.1186\/ar3503","article-title":"The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab","volume":"13","author":"Hammer","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13075-020-02163-6","article-title":"Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes","volume":"22","author":"Gabay","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.008599","article-title":"Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis","volume":"63","author":"Nissinen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1515\/CCLM.2006.012","article-title":"Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA","volume":"44","author":"Xu","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.099549","article-title":"Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis","volume":"54","author":"De Seny","year":"2008","journal-title":"Clin Chem"},{"key":"B40","article-title":"Screening disease-associated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study","volume":"123","author":"Li","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22050805","article-title":"Identification and Validation of SAA4 as a Rheumatoid Arthritis Prescreening Marker by Liquid Chromatography Tandem-mass Spectrometry","volume":"22","author":"Seok","year":"2017","journal-title":"Molecules"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.06.044","article-title":"Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis","volume":"204","author":"Nys","year":"2019","journal-title":"Talanta"},{"key":"B43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/art.1780210615","article-title":"The amyloidosis of juvenile rheumatoid arthritis\u2013comparative studies in Polish and American children. I. Levels of serum SAA protein","volume":"21","author":"Filipowicz-Sosnowska","year":"1978","journal-title":"Arthritis Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/ard.39.3.228","article-title":"Serum amyloid protein levels in south american children with rheumatoid arthritis: A co-operative study","volume":"39","author":"Scheinberg","year":"1980","journal-title":"Ann Rheum Dis"},{"key":"B45","article-title":"Immunoglobulin light chain levels can be used to determine disease stage in children with juvenile idiopathic arthritis","volume":"24","author":"Kutulculer","year":"2011","journal-title":"Clin Lab Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2012.53.5.1045","article-title":"Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis","volume":"53","author":"Cantarini","year":"2012","journal-title":"Yonsei Med J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_339_19","article-title":"Study of role of serum amyloid A (SAA) as a marker of disease activity in juvenile idiopathic arthritis","volume":"8","author":"Dev","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/ar1723","article-title":"Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy","volume":"7","author":"Miyamae","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050114","article-title":"Serum amyloid A\u2013an indicator of inflammation in ankylosing spondylitis","volume":"19","author":"Lange","year":"2000","journal-title":"Rheumatol Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2007.48.2.218","article-title":"Serum amyloid A as a useful indicator of disease activity in patients with ankylosing spondylitis","volume":"48","author":"Jung","year":"2007","journal-title":"Yonsei Med J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/art.24838","article-title":"Erythrocyte Sedimentation Rate, C-reactive Protein Level, and Serum Amyloid a Protein for Patient Selection and Monitoring of Anti-Tumor Necrosis Factor Treatment in Ankylosing Spondylitis","volume":"61","author":"De Vries","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"B52","article-title":"Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics","volume":"28","author":"Li","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez025","article-title":"Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis","volume":"58","author":"Rademacher","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00231","article-title":"Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study","volume":"11","author":"Wu","year":"2020","journal-title":"Front Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.9b00676","article-title":"Discovery of Potential Serum Protein Biomarkers in Ankylosing Spondylitis Using Tandem Mass Tag-Based Quantitative Proteomics","volume":"19","author":"Liu","year":"2020","journal-title":"J Proteome Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2009.09.038","article-title":"Circulation levels of acute phase proteins in patients with Takayasu arteritis","volume":"51","author":"Ma","year":"2010","journal-title":"J Vasc Surg"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3786-2","article-title":"Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis","volume":"37","author":"Nair","year":"2017","journal-title":"Rheumatol Int"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e3210","DOI":"10.1097\/MD.0000000000003210","article-title":"Do Early Diagnosis and Glucocorticoid Treatment Decrease the Risk of Permanent Visual Loss and Early Relapses in Giant Cell Arteritis: A Prospective Longitudinal Study","volume":"95","author":"Hocevar","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4240-x","article-title":"Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-na\u00efve patients","volume":"38","author":"Burja","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102428","article-title":"Serum amyloid A as a marker of disease activity in Giant cell arteritis","volume":"19","author":"Dartevel","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez034","article-title":"Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis","volume":"58","author":"Van Sleen","year":"2019","journal-title":"Rheumatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/01.CIR.0000151311.38708.29","article-title":"Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease","volume":"111","author":"Mitani","year":"2005","journal-title":"Circulation"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e0157024","DOI":"10.1371\/journal.pone.0157024","article-title":"A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease","volume":"11","author":"Whitin","year":"2016","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2017.11.006","article-title":"Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura","volume":"52","author":"Purevdorj","year":"2018","journal-title":"Clin Biochem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4234-8","article-title":"Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis","volume":"38","author":"Kuret","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1975","article-title":"Comparative evaluation of serum markers in pulmonary sarcoidosis","volume":"137","author":"Miyoshi","year":"2010","journal-title":"Chest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2001.00913.x","article-title":"and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders","volume":"31","author":"Salazar","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.12.010","article-title":"Analysis of serum amyloid A in sarcoidosis patients","volume":"105","author":"Bargagli","year":"2011","journal-title":"Respir Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.01.015","article-title":"Conventional markers in determination of activity of sarcoidosis","volume":"25","author":"Gungor","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-18","article-title":"Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients","volume":"14","author":"Zhang","year":"2013","journal-title":"Respir Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.10.010","article-title":"Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis","volume":"500","author":"Enyedi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1136\/ard.43.4.586","article-title":"Serum amyloid A protein concentration in progressive systemic sclerosis (scleroderma)","volume":"43","author":"Brandwein","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0110820","DOI":"10.1371\/journal.pone.0110820","article-title":"Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis","volume":"10","author":"Lakota","year":"2015","journal-title":"PloS One"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518760955","article-title":"High acute phase protein levels correlate with pulmonary and skin involvement in patients with diffuse systemic sclerosis","volume":"46","author":"Lis-\u015awi\u0119ty","year":"2018","journal-title":"J Int Med Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e923290","DOI":"10.12659\/MSM.923290","article-title":"Serum Amyloid A: A Potential Biomarker Assessing Disease Activity in Systemic Lupus Erythematosus","volume":"26","author":"Wang","year":"2020","journal-title":"Med Sci Monit"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1729129","article-title":"Correlation of serum protein biomarkers with disease activity in psoriatic arthritis","volume":"16","author":"Boyd","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"B78","article-title":"Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever","volume":"21","author":"Duzova","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei279","article-title":"Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations","volume":"45","author":"Lachmann","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2007.03.005","article-title":"A Single Testing of Serum Amyloid A Levels as a Tool for Diagnosis and Treatment Dilemmas in Familial Mediterranean Fever","volume":"37","author":"Berkun","year":"2007","journal-title":"Semin Arthritis Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0265-6","article-title":"The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study","volume":"27","author":"Yal\u00e7inkaya","year":"2007","journal-title":"Rheumatol Int"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114363","article-title":"Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever","volume":"69","author":"Kallinich","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7354018","article-title":"Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever","volume":"1","author":"Lofty","year":"2016","journal-title":"Int J Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/RHU.0000000000001134","article-title":"The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods","volume":"27","author":"Cakan","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0605-9","article-title":"Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis","volume":"28","author":"Bilginer","year":"2008","journal-title":"Rheumatol Int"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2020.05.005","article-title":"Carotid intima-media thickness, lipid profile, serum amyloid A and vitamin D status in children with familial Mediterranean fever","volume":"42","author":"Mohamed","year":"2020","journal-title":"Egyptian Rheumatologist"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-13-S1-O16","article-title":"Endothelial biomarkers in patients with familial Mediterranean fever associated vascular disease and vasculopathy","volume":"13","author":"Sargsyan","year":"2015","journal-title":"Pediatr Rheumatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00296-002-0180-4","article-title":"Kirazli A.Serum beta 2-microglobulin reflects disease activity in Beh\u00e7et\u2019s disease","volume":"22","author":"Ayg\u00fcnd\u00fcz","year":"2002","journal-title":"Rheumatol Int"},{"key":"B89","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/cei.12768","article-title":"et al. Immunometabolic biomarkers of inflammation in Beh\u00e7et\u2019s disease: relationship with epidemiological profile, disease activity and therapeutic regimens","volume":"184","author":"Cantarini","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2555-9","article-title":"Serum amyloid A in Behcet\u2019s disease","volume":"33","author":"Vitale","year":"2014","journal-title":"Clin Rheumatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0740-4","article-title":"Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Beh\u00e7et\u2019s Disease","volume":"20","author":"Sota","year":"2018","journal-title":"Isr Med Assoc J"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4606-y","article-title":"Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Beh\u00e7et\u2019s Disease","volume":"62","author":"Lee","year":"2017","journal-title":"Digestive Dis Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/art.2003","article-title":"Spectrum of Clinical Features in Muckle-Wells Syndrome and Response to Anakinra","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheumatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2481-2","article-title":"Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin1\u03b2 monoclonal antibody canakinumab","volume":"34","author":"Scarpioni","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.09.009","article-title":"Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study","volume":"34","author":"Hoffman","year":"2012","journal-title":"Clin Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (Interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheumatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4196-x","article-title":"Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study","volume":"37","author":"Wik\u00e9n","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902941","article-title":"Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis\/SCID mouse chimera model","volume":"184","author":"Connolly","year":"2010","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine","article-title":"Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis","volume":"42","author":"Ishii","year":"2003","journal-title":"Intern Med"},{"key":"B100","article-title":"Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis","volume":"75","author":"Migita","year":"1996","journal-title":"Lab Invest"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1177\/1753425919870847","article-title":"In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis","volume":"25","author":"Gorlier","year":"2019","journal-title":"Innate Immun"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0875-3","article-title":"Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis","volume":"27","author":"Perry","year":"2008","journal-title":"Clin Rheumatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes190","article-title":"Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis","volume":"51","author":"Nakamura","year":"2012","journal-title":"Rheumatol (Oxford)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.844294","article-title":"Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis","volume":"24","author":"Miyagawa","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B107","article-title":"Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature","volume":"33","author":"Lane","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.854048","article-title":"Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases","volume":"24","author":"Okuda","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.012","article-title":"Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China","volume":"81","author":"Xu","year":"2020","journal-title":"J Infect"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2020.04.011","article-title":"Association of viral load with serum biomakers among COVID-19 cases","volume":"546","author":"Shi","year":"2020","journal-title":"Virology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12879-020-05242-w","article-title":"Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.035","article-title":"Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis","volume":"80","author":"Li","year":"2020","journal-title":"J Infection"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.053","article-title":"Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China","volume":"94","author":"Li","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13840","article-title":"Serum amyloid A is a predictor for prognosis of COVID-19","volume":"25","author":"Mo","year":"2020","journal-title":"Respirology"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1559","article-title":"Use of somatic cell hybrids and fluorescence in situ hybridization to localize the functional serum amyloid A (SAA) genes to chromosome 11p15.4-p15.1 and the entire SAA superfamily to chromosome 11p15","volume":"23","author":"Watson","year":"1994","journal-title":"Genomics"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e0217005","DOI":"10.1371\/journal.pone.0217005","article-title":"Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages","volume":"14","author":"Jumeau","year":"2019","journal-title":"PloS One"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1991.10.651","article-title":"Nonexpression of the human serum amyloid A three (SAA3) gene","volume":"10","author":"Kluve-Beckerman","year":"1991","journal-title":"DNA Cell Biol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1993.1209","article-title":"A constitutively expressed serum amyloid A protein gene is closely linked to, and shares structural similarities with, an acute phase serum amyloid A protein gene","volume":"16","author":"Steel","year":"1993","journal-title":"Genomics"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13506129.2014.980942","article-title":"Risk factors for AA amyloidosis in Germany","volume":"22","author":"Blank","year":"2015","journal-title":"Amyloid"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3109\/13506129809007299","article-title":"SAA1 alleles as risk factors in reactive systemic AA amyloidosis","volume":"5","author":"Booth","year":"1998","journal-title":"Amyloid"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0435-7","article-title":"SAA1 alpha\/alpha alleles in Behcet\u2019s disease related amyloidosis","volume":"26","author":"Utku","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s004399900150","article-title":"Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis","volume":"105","author":"Moriguchi","year":"1999","journal-title":"Hum Genet"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-006-0500-8","article-title":"SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis","volume":"16","author":"Ajiro","year":"2006","journal-title":"Mod Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei112","article-title":"Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis","volume":"45","author":"Nakamura","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3","article-title":"A novel single-nucleotide polymorphism at the 50-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis","volume":"44","author":"Moriguchi","year":"2001","journal-title":"Arthritis Rheumatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/13506120308995250","article-title":"An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians","volume":"10","author":"Yamada","year":"2003","journal-title":"Amyloid"},{"key":"B127","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/13506120500032394","article-title":"Relative transcriptional activities of SAA1 promoters polymorphic at position -13(T\/C): potential association between increased transcription and amyloidosis","volume":"12","author":"Moriguchi","year":"2005","journal-title":"Amyloid"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2004.01369.x","article-title":"Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines","volume":"59","author":"Thorn","year":"2004","journal-title":"Scand J Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2005.00900.x","article-title":"Essential role of STAT3 in cytokine-driven NF-\u03baB-mediated serum amyloid A gene expression","volume":"10","author":"Hagihara","year":"2005","journal-title":"Genes Cells"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101362","article-title":"Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synovium","volume":"38","author":"Migita","year":"2011","journal-title":"J Rheumatol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.12.096","article-title":"IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system","volume":"314","author":"Hagihara","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6612-4_15","article-title":"Pathogenic Role of IL-6 Combined with TNF-alfa or IL-1 in the Induction of Acute Phase Proteins SAA and CRP in Chronic Inflammatory Diseases","volume":"691","author":"Yoshizaki","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb32318.x","article-title":"Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1","volume":"762","author":"Kushner","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1042\/bj2910701","article-title":"Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles or mRNA accumulation, poly (A) tail shortening and translational efficiency","volume":"291","author":"Steel","year":"1993","journal-title":"Biochem J"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1996.0072","article-title":"Kushner I. C-reactive protein and serum amyloid A mRNA stability following induction by cytokines","volume":"8","author":"Lozanski","year":"1996","journal-title":"Cytokine"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2003.08.025","article-title":"Interleukin-18 induces serum amyloid A (SAA) protein production from rheumatoid synovial fibroblasts","volume":"13","author":"Tanaka","year":"2004","journal-title":"Life Sci Feb"},{"key":"B137","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4049\/jimmunol.169.1.399","article-title":"Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2","volume":"1","author":"Thorn","year":"2002","journal-title":"JImmunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1186\/ar78","article-title":"Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue","volume":"2","author":"O\u2019Hara","year":"2000","journal-title":"Arthritis Res"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142240","article-title":"Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis","volume":"70","author":"Connolly","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.01.022","article-title":"Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes","volume":"582","author":"Koga","year":"2008","journal-title":"FEBS Lett"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.2143","article-title":"A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil","volume":"268","author":"Furlaneto","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.8.5585","article-title":"Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis","volume":"177","author":"Lee","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1431","article-title":"Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1\/LXA4R","volume":"101","author":"He","year":"2003","journal-title":"Blood"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.2353\/ajpath.2010.090014","article-title":"A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A","volume":"176","author":"Mullan","year":"2010","journal-title":"Am J Pathol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.03.254","article-title":"An involvement of SR-B1 mediated p38 MAPK signaling pathway in serum amyloid A-induced angiogenesis in rheumatoid arthritis","volume":"66","author":"Hong","year":"2015","journal-title":"Mol Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0407203","article-title":"Is serum amyloid A an endogenous TLR4 agonist","volume":"83","author":"Sandri","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2015.00109","article-title":"Serum amyloid A stimulates PKR expression and HMGB1 release possibly through TLR4\/RAGE receptors","volume":"21","author":"Li","year":"2015","journal-title":"Mol Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-139923","article-title":"Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2","volume":"113","author":"He","year":"2009","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.1.22","article-title":"Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A","volume":"181","author":"Cheng","year":"2008","journal-title":"J Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207655","article-title":"Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms","volume":"75","author":"Connolly","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12260","article-title":"Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-\u03baB","volume":"143","author":"O\u2019Reilly","year":"2014","journal-title":"Immunology"},{"key":"B152","article-title":"Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products","volume":"35","author":"Okamoto","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1002\/art.21518","article-title":"Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway","volume":"54","author":"Mullan","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"B154","article-title":"Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts","volume":"78","author":"Migita","year":"1998","journal-title":"Lab Invest"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2801","article-title":"Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases","volume":"166","author":"Vallon","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/art.20301","article-title":"Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis","volume":"50","author":"O\u2019Hara","year":"2004","journal-title":"Arthritis Rheumatol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165(2007)131[563:SLOMMS]2.0.CO;2","article-title":"Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis","volume":"131","author":"Kobayashi","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"B158","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/s10165-012-0630-0","article-title":"(SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes","volume":"23","author":"Satomura","year":"2013","journal-title":"Mod Rheumatol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6- expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep089","article-title":"Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes","volume":"48","author":"Migita","year":"2009","journal-title":"Rheumatol (Oxford)"},{"key":"B162","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.imlet.2018.10.013","article-title":"Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet\u2019s disease","volume":"201","author":"Lucherini","year":"2018","journal-title":"Immunol Lett"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1737-y","article-title":"Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA","volume":"30","author":"Metawi","year":"2011","journal-title":"Clin Rheumatol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1002\/art.24568","article-title":"Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis","volume":"60","author":"Shen","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"B165","article-title":"Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis","volume":"29","author":"Romero-Sanchez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12272","article-title":"Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial","volume":"28","author":"Bissonnette","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B168","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1186\/ar3849","article-title":"Serum amylodi A triggers the mosodium urate mediated mature interleukin 1\u00df production from human synovial fibroblasts","volume":"14","author":"Migita","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu359","article-title":"Dysregulated mature IL-1\u03b2 production in familial Mediterranean fever","volume":"54","author":"Migita","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002843","article-title":"Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway","volume":"186","author":"Niemi","year":"2011","journal-title":"J Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1084\/jem.139.3.773","article-title":"New, third class of amyloid fibril protein","volume":"139","author":"Husby","year":"1974","journal-title":"J\u00a0Exp Med"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01472.x","article-title":"Impaired degradation of serum amyloid A (SAA) protein by cytokine-stimulated monocytes","volume":"123","author":"Migita","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/13506120601116575","article-title":"Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model","volume":"14","author":"Magy","year":"2007","journal-title":"Amyloid"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)61727-0","article-title":"Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3","volume":"159","author":"Stix","year":"2001","journal-title":"Am J Pathol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken371","article-title":"Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis","volume":"47","author":"Van der Hilst","year":"2008","journal-title":"Rheumatol (Oxford)"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvs089","article-title":"High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A","volume":"94","author":"Tolle","year":"2012","journal-title":"Cardiovasc Res"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.20.3.763","article-title":"Role of serum amyloid A during metabolism of acute-phase HDL by macrophages","volume":"20","author":"Artl","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-016-0229-0","article-title":"High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus","volume":"15","author":"Gaal","year":"2016","journal-title":"Lipids Health Dis"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.8.3186","article-title":"Expression of apolipo-protein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function","volume":"91","author":"Meek","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1096\/fj.00-0247com","article-title":"Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells","volume":"15","author":"Mechtcheriakova","year":"2001","journal-title":"FASEB J"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.106.137455","article-title":"Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells","volume":"27","author":"Zhao","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160511101","article-title":"Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells","volume":"16","author":"Chami","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.06.031","article-title":"The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein","volume":"51","author":"Witting","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.551","article-title":"Cholesterol modulates glycolipid conformation and receptor activity","volume":"7","author":"Lingwood","year":"2011","journal-title":"Nat Chem Biol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mvr.2013.07.011","article-title":"Serum amyloid A activation of human coronary artery endothelial cells exhibits a neutrophil promoting molecular profile","volume":"90","author":"Lakota","year":"2013","journal-title":"Microvasc Res"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00238.2008","article-title":"Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells","volume":"295","author":"Wang","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02555.x","article-title":"Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts","volume":"137","author":"Migita","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1289908","article-title":"Detection of adalimumab and antibodies to adalimumab using a homogeneous mobility shift assay","volume":"33","author":"Rubin","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1002\/art.39217","article-title":"Regulation of Inflammation and Angiogenesis in Giant Cell Arteritis by Acute-Phase Serum Amyloid A","volume":"67","author":"O\u2019Neill","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.03.002","article-title":"Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum","volume":"101","author":"Bons","year":"2007","journal-title":"Respir Med"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00092","article-title":"Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors","volume":"22","author":"Christenson","year":"2013","journal-title":"Front Immunol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1002\/art.27440","article-title":"The proinflammatory activity of recombinant serum amyloid A is not shared by the endogenous protein in the circulation","volume":"62","author":"Bjorkman","year":"2010","journal-title":"Arthritis Rheumatol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.2.124","article-title":"Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis","volume":"60","author":"Yamada","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-019-01996-8","article-title":"Serum amyloid A levels are associated with polymorphic variants in the serum amyloid A 1 and 2 genes","volume":"188","author":"Griffiths","year":"2019","journal-title":"Ir J Med Sci"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.279372","article-title":"Copy number variations in serum amyloid A play a role in the determination of its individual baseline concentrations","volume":"64","author":"Zhang","year":"2018","journal-title":"Clin Chem"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1011","article-title":"Diet-induced weight loss is associated with decreases in plasma serum amyloid A and C-reactive protein independent of dietary macronutrient composition in obese subjects","volume":"90","author":"O\u2019Brien","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.5551\/jat.3632","article-title":"Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels","volume":"17","author":"Horiuchi","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.03.052","article-title":"The effects of diet on inflammation: emphasis on the metabolic syndrome","volume":"48","author":"Giugliano","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2006.08.003","article-title":"An explanation for the paradoxical induction and suppression of an acute phase response by ethanol","volume":"39","author":"Pruett","year":"2006","journal-title":"Alcohol"},{"key":"B203","article-title":"Serum amyloid-A protein and serum rheumatoid factor as serological surrogate markers for smoking risk factor in Saudi population","volume":"26","author":"Al-Sieni","year":"2013","journal-title":"Pak J Pharm Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.631299\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T12:29:52Z","timestamp":1697891392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.631299\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":203,"alternative-id":["10.3389\/fimmu.2020.631299"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.631299","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"article-number":"631299"}}